Two weight loss drugs approved in India

 

The Expert Committee of the Drug Control General of India has approved the import and marketing of the drug Tireceptide, which is widely used in foreign countries to control diabetes and reduce weight. The drug is manufactured by Eli Lilly and is marketed in the United States under the names Mounjaro and Sepbound. The Drug Control General of India will give the final approval based on the recommendations of the expert committee.

Studies show that this injectable drug can help reduce body weight by up to 18 percent. Mounjaro is intended for diabetes and Sepbound weight loss.

The drug in injectable form containing six different doses ranging from 2.5 mg to 12.5 mg was approved by an expert panel in India based on two global clinical trials. The study found that tirceptide was able to reduce weight by 18 percent over 72 weeks in adults without type 2 diabetes. The drug was also able to reduce an average of 12 percent weight in diabetics.